Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
46
pubmed:dateCreated
2005-11-18
pubmed:abstractText
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease (PD) with a clinical appearance indistinguishable from idiopathic PD. Initial studies suggest that LRRK2 mutations are the most common yet identified determinant of PD susceptibility, transmitted in an autosomal-dominant mode of inheritance. Herein, we characterize the LRRK2 gene and transcript in human brain and subclone the predominant ORF. Exogenously expressed LRRK2 protein migrates at approximately 280 kDa and is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Familial-linked mutations G2019S or R1441C do not have an obvious effect on protein steady-state levels, turnover, or localization. However, in vitro kinase assays using full-length recombinant LRRK2 reveal an increase in activity caused by familial-linked mutations in both autophosphorylation and the phosphorylation of a generic substrate. These results suggest a gain-of-function mechanism for LRRK2-linked disease with a central role for kinase activity in the development of PD.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-11891824, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-12547187, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-12588799, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-14593166, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-14713311, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15087508, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15136696, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15350212, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15525661, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15541308, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15541309, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15680455, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15680456, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15680457, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15726496, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-15944198, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-16157908, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-16157909, http://linkedlifedata.com/resource/pubmed/commentcorrection/16269541-16275903
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16842-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.
pubmed:affiliation
Institute for Cell Engineering, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural